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ABSTRACT
Surgery is still the golden standard of curative therapy for malignant biliary obstruction, but only 10-
20% of cases considered resectable. Therefore, palliative therapy to relieve pain, cholestasis, and biliary
obstruction, is the main treatment for most patients. The development of  percutaneous transhepatic biliary
drainage and endoscopic biliary drainage had brought about minimally invasive treatment for malignant
biliary obstruction, which had lower morbidity and mortality than surgical drainage. The choice of drainage
technique depends on type of tumor , site of obstruction, also the available expert and instrumentation.
Key words: malignant biliary obstruction, percutaneous transhepatic biliary drainage, therapeutic endo-
scopic retrograde cholangiopancreatography
INTRODUCTION
Biliary obstruction is an emergency biliary and liver
emergency that requires careful, precise and compre-
hensive treatment from internists, surgeons and radiolo-
gists.1,2 Biliary obstruction can be caused by various
malignancies, such as cholangiocarcinoma, pancreatic
carcinoma, carcinoma of the bile duct, malignancies in
the liver and duodenum, as well as metastases of colon
carcinoma. 1,3
In developed nations, billiopancreatic malignancy is
the fifth largest cause of death due to cancer after lung
cancer, colorectal cancer, breast cancer, and prostate
cancer.4 Pancreatic carcinoma itself is the fourth larg-
est cause of death due to cancer in the United States.5,6
Even though biliary malignancy is less commonly found,
its mortality rate is still high – almost 4000 deaths annu-
ally.6
From the year 1994 to 1998, periampula tumor was
the most common cause of biliary obstruction out of 62
reported cases (54.8%) at the surgery department of dr.
Cipto Mangunkusumo National Public Hospital – Re-
ferral Center. From 1999 to 2000, periampula caused
58% of all reported cases of biliary obstruction.7
Biliary obstruction due to malignancy was once
known as surgical jaundice, since the gold standard for
therapy was by surgical means.3,6,8 However, since most
patients came in advanced stages, only 10-20% of cases
could still undergo curative therapy by means of sur-
gery.5,8,9 Thus, most patients receive palliative therapy.9
At first, drainage using bilio-digestive anastomosis
was more commonly used to eliminate biliary obstruc-
tion. However, palliative surgical therapy is often corre-
lated with a high mortality rate (15-30%) and morbidity
rate (20-60%).(9) Other reports mention a post-surgical
mortality rate of 30-65% for patients with biliary obstruc-
tion due to malignancy.10
Development of minimally invasive therapy in the past
two decades has brought dramatic changes in modern
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Table 1. The cause of biliary obstruction due to 
malignancy, based on location.16 
Proximal Distal 
Cholangiocarcinoma Carcinoma of the pancreas 
Adenopathy Cholangiocarcinoma 
Carcinoma of the 
gallbladder 
Adenopathy 
Hepatoma Carcinoma of the ampulla 
 Carcinoma of the duodenum 
 
medicine. Minimally invasive therapy has been accepted
and has been widely used in various organs. So far, it is
most widely applied in the hepatobiliary system.11 The
high rate of mortality and morbidity in surgical palliative
therapy has also stimulated the introduction of minimally
invasive therapy in cases of biliary obstruction due to
malignancy. Since the introduction of percutaneous
transhepatic drainage in the year 1962, there has been
much development in palliative therapy of biliary obstruc-
tion due to malignancy.12-14 A widely used technique is
the Percutaneous Transhepatic Biliary Drainage (PTBD)
and Endoscopic Biliary Drainage (EBD).3,11,15
BILIARY OBSTRUCTION DUE TO MALIGNANCY
Biliary obstruction is caused by blockage of one or
more bile ducts that dispenses bile from the liver to the
gallbladder, or from the gallbladder to the duodenum.
Symptoms of biliary obstruction are related to bile flow
obstruction and increased serum bilirubin. The patient
may suffer from pruritus, yellowish eyes and skin (jaun-
dice), brownish (tea-like) urine, acholic feces, cholangi-
tis, even liver failure.5
Diagnosis of biliary obstruction is established based
on anamnesis and physical examination, increased liver
function (transaminase, alkaline phosphatase, and biliru-
bin), as well as ultrasonographic findings of intra and
extra-hepatic biliary tracts. Ultrasound examination could
also assist approximation of the location of obstruction.
Enlargement of the common bile duct and gallbladder
indicate obstruction at the distal, while enlargement of
the intra-hepatic bile duct without enlargement of the
common bile duct indicate obstruction at the proximal of
the common hepatic duct.16
Carcinoma of the gallbladder is the most common
biliary tract malignancy. Over 50% of patients with gall-
bladder carcinoma are found with distant metastasis at
the time of the initial diagnosis. The patient’s prognosis
is poor, with a median life expectancy of 3 more months.
Only 14% survive the first year.17
Patients with cholangiocarcinoma have better prog-
nosis, with a median life expectancy of 18-30 months
with surgery and 5 months without. If the
cholangiocarcinoma is located at the distal, the survival
rate is even better – over 50% for the first 3 years, with
a median life expectancy of 24 months.8,17
Carcinoma of the pancreas is the most common ma-
lignancy at the distal (70%). The rest comprise of distal
cholangiocarcinoma, adenocarcinoma of the duodenum,
and adenocarcinoma of the ampulla.6 Prognosis of car-
cinoma of the pancreas, with a 5 year survival rate of
3% and a median life expectancy of 3-4 months.18
Palliative therapy of biliary obstruction due to malig-
nancy is aimed at alleviation of pain symptoms,
cholestasis, biliary obstruction, and improving the patient’s
quality of life. Thus, palliative therapy should have mini-
mal morbidity rate and should be able to relieve the pa-
tient of pain and biliary obstruction as well as its conse-
quences.5,9
NON-OPERATIVE BILIARY DRAINAGE
Biliary drainage was first introduced by Glenn, et al
in the year 1962, who placed a catheter for external drain-
age after percutaneous transhepatic cholangiography. At
the time, the catheter was inserted percutaneously for 5
days to prevent intraperitoneal leakage of the bile, which
is the main complication of the examination.3,12-14
Such external drainage has the disadvantage of dis-
turbing the patient, who has to carry a bag containing
the fluid that comes out of the external catheter. Fur-
thermore, the use of an external drainage also results in
electrolyte loss and other metabolic disturbances.3,15
To prevent these problems, the internal drainage with
an internal-external catheter was invented. The
transhepatic catheter with a side hole was placed above
and below the point of obstruction down to the duode-
num, so that the bile flows through the catheter into the
duodenum. This kind of catheter must be routinely re-
placed every 3 months to prevent obstruction. This kind
of catheter also has several disadvantages, such as hav-
ing the patient constantly reminded of his or her illness,
difficulty maintaining, and it is often a potential source of
infection. Since then, the internal catheter has developed
and became widely used.3
General indication for biliary drainage in cases of
malignant biliary obstruction is jaundice accompanied with
cholangitis, sepsis, pruritus, as well as nausea and vom-
iting which could cause dehydration and malnutrition.
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Figure 1. Steps of percutaneous transhepatic biliary drainage
a.      Diagnostic percutaneous transhepatic cholangiography
b-d.  Biliary drainage using an external catheter or a combination of external and internal catheters
e,f.   Internal drainage using endoprothesis
Biliary drainage is also often performed prior to surgery.
The catheter, placed in the extra-hepatic bile duct, could
assist the surgeon in making the anastomosis.3,19 On the
other hand, since pre-operative drainage increases post-
surgical morbidity and mortality rate, such therapy should
undergo careful consideration and should only be indi-
cated if the patient shows signs of acute cholangitis, se-
vere obstructive jaundice, or there are plans for other
neo-adjuvant therapy.3,20
PERCUTANEOUS TRANSHEPATIC BILIARY DRAINAGE
Percutaneous transhepatic biliary drainage is per-
formed in two steps, percutaneous transhepatic cholan-
giography (PTC), followed by insertion of the catheter
assisted by fluoroscopy or ultrasonography.12,21
Indication and Contraindication
PTC is indicated for palliative drainage in biliary ob-
struction due to malignancy with high risk for surgery
and difficulty to perform endoscopic drainage, as well
as for pre-operative drainage to improve the patient’s
general condition.2,4,19 Suda, et al has also used the tech-
nique for nutritional support.22
This procedure is contraindicated for patients who
are uncooperative, those with coagulation disturbance,
and severe cholangitis. Patients with widespread hepatic
metastasis are not advised to undergo this procedure
since drainage is not very successful and there is a
greater possibility for complication. Ascites is also a con-
traindication, since it facilitates the development of peri-
tonitis.12
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Technique and Instrumentation
Routine preparations include prophylaxis antibiotics,
examination of bleeding and clotting time, premedications,
sterilization, and informed consent.11,12 The patient should
fast at least 6 hours prior to the procedure.2
Procedure
We must first identify an easy to reach duct in the
right or left hepatic lobe. Assisted by fluoroscopy, the
horizontal section of the right hepatic duct is easily
reached. To access the spot, the syringe should be in-
serted from the right lateral.2,21 Guided by an ultrasound,
the syringe may be inserted from other directions. To
avoid the possibility of transpleural laceration, acciden-
tal removal of the catheter, or bending of the catheter in
the space between the liver and the abdominal wall, it is
advisable to insert the syringe from the anterior towards
the left lobe. In addition, anterior insertion provides more
comfort for the patient.21 This method is also performed
if there is stricture in the left hepatic duct.23 An 18-22
gauge syringe needle should be inserted while the pa-
tient holds his or her breath.
The next step is ultrasound or fluoroscopy guided
percutaneous transhepatic cholangiography. After the
syringe is inserted at the proper position, the bile is aspi-
rated, and then the contrast is injected and fluoroscopy
and radiography are conducted in several positions.
After a cholangiogram is performed, the guiding shaft
is inserted into the bile duct from the needle. A pig-tail
catheter with several side outlets is inserted through the
guiding shaft into the bile duct. The shaft can then be
removed. If an external catheter is being used, the cath-
eter is then stitched on the skin for fixation and a three-
way stopcock is placed.
Post-insertion care of an external catheter include
irrigation using 15-20 ml of physiologic alkaline fluid twice
daily, measurement of excreted bile fluid, and monitor-
ing of bilirubin and alkaline phosphatase levels. In addi-
tion, routine check of electrolyte levels and abdominal x-
ray to determine catheter position should be performed.21
Success Rate
Current reports demonstrate that percutaneous
transhepatic biliary drainage is an effective method for
biliary drainage in cases of biliary obstruction due to
malignancy. Ferrucci, et al, reported a success rate of
93.5% in 62 patients for drainage using this technique.21
Hamlin, et al, reported a success rate of 97%.25 Sirinek,
et al, even reported an initial success rate of up to 98%
in 221 patients.26 Percutaneous transhepatic biliary drain-
age of the left love in the 89 patients reported by Kaufman,
et al, achieved a success rate of 92%.23
Reduction of bilirubin to normal occurs in 22.5%
cases reported by Ferrucci, et al, while 50% of patients
experience reduction of bilirubin up to 10 mg. This re-
duction of bilirubin occurs within an average of 11.2 days
following the procedure.14,21
Complication
Even though the success rate is high, percutaneous
transhepatic biliary drainage often creates minor as well
as major complications (21-69%). Minor complications
in question are complications that only require medical
management, correction of the position of the catheter,
or without specific therapy. Major complications include
those that require radiological or surgical intervention,
blood transfusion, or those that are fatal.25
Table 2. Major and minor complications of 
percutaneous transhepatic biliary drainage 21,25-27 
Complication Hamlin, 
et al 
Ferrucci 
et al 
Sirinek, 
et al 
Carrasco, 
et al 
Minor     
Haemobillia 16 DU DU 7 
Fever 14 DU DU DU 
Leukocytosis 12 DU DU DU 
Cholangitis DU 14.5 48.9 47 
Hypotension 7.6 DU DU DU 
Catheter 
obstruction 
DU DU DU 14 
Bile leakage DU DU 6.1 16 
Accidental 
catheter removal 
3.4 DU DU 18 
Others 1.7 4.8 DU DU 
Major     
Bleeding 1.7 3.2 8.1 DU 
Septic shock/ 
subphrenic 
abscess 
1.7 1.6 2 DU 
Peritonitis 2.6 DU DU DU 
Arteriovenous/ 
biliopleural fistula 
0.8 DU DU 2.5 
Others DU DU DU 0.6 
DU: Data Unavailable 
  
Mueller and McPherson divided the complications of
transhepatic biliary drainage into acute and late-onset
complications, as seen in Table 3.
Death occurs in 15-32% of patients that undergo this
procedure. Death may be due to accidental removal of
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Table 3. Acute and late-onset complications of 
percutaneous transhepatic biliary drainage.14,28 
Complication Mueller, 
et al (%) 
McPherson,  
et al (%) 
Acute   
Bleeding 5.0 DU 
Sepsis 3.7 DU 
Fever 11.1 DU 
Haemobillia 9.5 5.4 
Intraperitoneal bile leakage DU 8.1 
Abdominal discomfort DU 81 
Bowel perforation DU 2.7 
Late onset   
Cholangitis/bacteremia 20.7 27 
Catheter leakage 4.2 DU 
Catheter bending 5.8 10.8 
Intrahepatic abscess DU 5.4 
Drainage obstruction 3.7 DU 
DU: Data Unavailable 
Figure 2. Nasobiliary drainage insertion on a tumor
located at the bifurcation (Klatksin type I).34 A. A guide
wire and size 10 Fr nasobiliary tube is shoved through the
common biliary duct after the sphincterotomy. B. The
nasobiliary is shoved through the obstructed area, while
the guide wire is removed. C. The endoscope is removed.
in the year 1976. Two years afterwards (1978),
Soehendra, Cotton, and Huibregtse placed the first
bilioduodenal endoprothesis using endoscopy.30,31
Indication and Contraindication
Endoscopic biliary drainage is the chief palliative
therapy in biliary obstruction due to malignancy in pa-
tients with old age, or those with contraindications for
surgical procedures. This procedures is also indicated
as pre-surgical drainage in cases where resection could
still be performed to reduce the mortality rate due to
surgical procedures.30,32
This procedure could not be performed on patients
with manifestations of blood coagulation disturbances or
uncooperative patients.30,33
Preparation
Routine preparations include prophylaxis antibiotics,
examination of bleeding and clotting time, premedications,
sterilization, and informed consent.11,12 The patient should
fast at least 6 hours prior to the procedure.11,12
ENDOSCOPIC NASOBILIARY DRAINAGE
This technique is performed using a size 5-7 Fr
nasobiliary tube with Endoscopic Retrograde
Cholangiopancreatography (ERCP).2,34
Technique
After ERCP canulation and contrast injection, a
sphincterotomy is performed to facilitate catheter inser-
tion. The papilla vateri is cut with an electric current
the catheter, causing peritonitis and sepsis (44%), post-
procedural sepsis (33%), bile hypersecretion (11%), and
formation of a biliopleural fistula after catheter removal
(11%).4,25,27 Bleeding has also been reported as a cause
of post-procedural death.25
ALTERNATIVE PERCUTANEOUS PROCEDURES
· Drainage with percutaneous cholecystography
This procedure is useful for obstructions below
the level of the cystic duct. It can be conducted if
transhepatic biliary drainage fails, but it is only tem-
porary. The technique is not very different from per-
cutaneous transhepatic biliary drainage.12
· Drainage with percutaneous transjejenal procedure
In this procedure, the catheter is inserted percu-
taneously through a previously constructed
biliojejunal Roux-en-Y anastomosis towards the bil-
iary duct. This procedure is performed to keep the
endoprothesis in place for a long period of time.12,29
ENDOSCOPIC BILIARY DRAINAGE
External and internal biliary drainage may be per-
formed using endoscopy. External drainage is performed
using the nasobiliary tube, while internal drainage is per-
formed using endoprothesis.
The first nasobiliary drainage was introduced by Nagai
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wire, thus enlarging the mouth of the papilla vateri.2,34,35
A guide wire is then inserted into the collecting duct.
The nasobiliary tube is inserted into the collecting duct
through the guide wire. After its tip is located at the
proximal (common hepatic duct/intrahepatic duct), the
guide wire is removed. The spade is then removed while
the nasobiliary tube is inserted further to prevent acci-
dental removal. The proximal tip of the nasobiliary tube
is replaced from the mouth to the nostrils with a hook, or
is attached to a common nasogastric tube until it is posi-
tion like a nasogastric tube and is fixated on the face.
The bile is collected in a sterile plastic bag.2,34
Usage of the nasobiliary tube facilitates periodic cho-
langiography without repeated endoscopy.34
Figure 3. Endoscopic insertion of the nasobiliary tube34
A. The endoscope is removed. B. The nasopharyngeal tube is inserted through the nostril through the pharynx, and then
extracted through. C. The proximal part of the nasobiliary tube is attached to the nasoparyngeal tube. D. Both tubes are
reinserted to the mouth while the tube is extracted through the nostril. E. The proximal portion of the nasobiliary tube is
attached to the drainage bag.
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Figure 5. Schematic illustration of endoscopic insertion of
an endoprothesis.30
ENDOSCOPIC INTERNAL DRAINAGE
(ENDOPROTHESIS)
Technique
Similar to insertion of the nasobiliary tube, after ERCP
canulation, contrast injection and sphincterotomy (if nec-
essary), the guide wire is inserted into the collecting duct.
A biliary stent/endoprothesis that fits the patient’s com-
mon bile duct is then inserted through the wire with the
endoscope. After the endoprothesis is inserted into the
common bile duct with its distal tip out side the papilla
vateri, the guide wire is removed, leaving the
endoprothesis at the site of obstruction.2,4,30-33,37
Success Rate
The technique for endoscopic insertion of
endoprothesis demonstrates a high success rate (84-92%)
for cases of tumor at the periampula, distal, or the pan-
creas; and is able to eliminate jaundice in more than 80-
97% of patients.4,37-39 The mortality rate for the first 30
days ranges from 4-22%.4 The success rate for several
kinds of cancer as seen in Table 3.
Complication
Initial complications occurring within 1 week after
the insertion of an endoprothesis is mostly due to the
sphincterotomy performed or the endoprothesis it-
self.4,30,32
Complications due to the sphincterotomy procedure
reported by Huibregtse, et al occur in 6-8% of all cases,
including bleeding, pancreatitis, and perforation of the
duodenum or biliary duct as seen in Table 3.4,32 Marquiles,
et al reported that sphincterotomy increases the possi-
bility of acute complications. Acute complications of
endoprothesis insertion occur in 8.3% patients that un-
dergo sphincterotomy and in only 1.2% of patients that
do not undergo sphincterotomy.40 The possibility of bleed-
ing is greater in patients with portal vein obstruction and
varices due to extension of pancreatic tumor as reported
as Cvertkovski, et al.41
The most significant acute complication due to
endoprothesis is acute cholangitis. Even though prophy-
lactic antibiotics have been administered prior to the pro-
cedure and the endoprothesis and other instruments have
been disinfected, contamination of bacteria from the
mouth and bowel during the procedure cannot be avoided.
Such bacterial contamination would cause cholangitis in
the case of incomplete biliary drainage. This explains
why cholangitis more often complicates tumors at the
bifurcatio (19%), since adequate drainage at this site is
more difficult.4,32 To deal with this problem, obstruction
at the bifurcatio is managed by inserting two
endoprothesis simultaneously. The success rate for drain-
age in the case where two endoprothesis are placed si-
multaneously is better than if only one endoprothesis is
inserted (88.6% compared to 76.9%),  thus reducing the
complication of cholangitis (8.8% compared to 16.6%).42
The incidence of cholangitis also increases with multiple
attempts to insert the endoprothesis.4
The main complication that could occur later on is
obstruction of the endoprothesis, which occurs in 21-
36% of cases, reported by Huibregtse, et al.4 Retrospec-
tive studies found cases of endoprothesis obstruction in
10-30% cases, while random prospective studies found
a higher rate of 21-52% with a total incidence of 42%.
Figure 4. Standard sphincterotomy/papillotomy. The
sphincter of the papilla vateri is cut using an electrocauter
that passes through the papillotome. The cauter is
directed towards the base of the papilla.36
guide wire
cutting wire
papillotome
Freeman ML et al, 1996
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Table 4. The outcome of endoscopic endoprothesis insertion in biliopancreatic 
cancer (Amsterdam).4,32 
 Ampulla Pancreas Gallbladder Bifurcatio 
Drainage success 
rate (%) 
96 90 86 84 
Bilirubin     
Reduced (%) 98 97 94 87 
Normal (%) within 30 
days 
96 94 84 68 
Mortality      
Due to the 
procedure (%) 
0 2 2 6 
Within 30 days (%) 2 9.5 20 23 
Median life 
expectancy (in 
months) 
13.5 5 4.5 3 
 
Table 5. Initial complication of endoprothesis in the first week.4,32 
Complication Incidence rate (%)   
Due to sphincterotomy    
Bleeding 1-2   
Pancreatitis 0-1   
Perforation 0-1   
Due to endoprothesis    
Acute cholecystitis 0-1   
Obstruction 1-2   
Acute cholangitis 7-19 Ampulla 7 
  Pancreas 8 
  Gallbladder 12 
  Bifurcatio 1 
Mortality due to the procedure 0-6  
 
The average time span for the endoprothesis to func-
tion prior to obstruction is 4.9 months (ranging from 1.4
to 9.2 months).43 Other complications such as acute
cholecystitis, endoprothesis migration and perforation is
rarely found. Cholecystitis may be due to stenosis of the
cystic duct, which occurs slowly, accompanied by con-
tinuous infection caused by the endoprothesis. Duode-
nal stenosis, which is commonly found, is not an actual
complication of this procedure, but instead is due to rapid
growth of the tumor.4,30,33
Preventing Endoprothesis Obstruction
Bile sediment is the substance that plays the greatest
role in obstructing the endoprothesis. It contains bilirubinic
calcium crystals, palmitic calcium, cholesterol, protein,
and bacteria.3,43,44 Bacteria encourages bile sedimenta-
tion, possibly due to the great number of bacteria that
adheres t the biofilm and bacterial enzymes such as beta-
glucoronidase, which is active in the bile. Bacteria found
in the endoprothesis include Escherichia coli, Klebsiella
oxytoca, Klebsiella pneumonia, Enterobacter cloa-
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cae, Citrobacter freundii, Pseudomonas aeruginosa
(gram negative), Enterokokus sp, Streptokokus sp,
Clostridium sp (gram positive).4,43,45 Duodenal reflux
also enhances obstruction of the endoprothesis.4
Many methods to prevent endoprothesis blockage are
still under trial.
Diameter of The Endoprothesis
This is the most widely accepted method to delay
endoprothesis obstruction. Siegel, et al, reported delayed
obstruction in the use of size 12 French endoprothesis
compared to 10 French.43 Pereira, et al reported similar
findings in a comparison between the use of 11,5 French
and 10 French endoprothesis, while Coene compared
size 10 French and 7 French endoprothesis.4,46 Never-
theless, current techniques only allow the use of a size
12 French endoprothesis, limited by the size of the
duodenoscope.43 To avoid this, self-expanding metal
stents (SEMS) with the ability to expand up to size 30
French was introduced. SEMS have been proven to re-
main functional twice as long compared to conventional
plastic endoprothesis. Obstruction occurs after 8 to 12
months due to tumor growth between and at the tip of
the endoprothesis. Unfortunately, SEMS is permanent,
is irreplaceable, and is more expensive.43,46,48-49
Type and Design of The Endoprothesis
Available endoprothesis are made of various materi-
als, including plastics (polyethylene, polyurethane, Teflon,
vivatan) and metal.44 Plastic endoprotheses is cheaper
and could be easily replaced, while metal endoprotheses
are difficult to replace.44,47 Since bacteria are suspected
to adhere by hydrophobic interaction, Costamagna, et al
tried to use a hydromer-coated polyurethane
endoprothesis, and compared it to the standard polyure-
thane endoprothesis. Even though the comparison did
not demonstrate statistically significant findings, the
coated endoprothesis function for a longer period of time
(103 days compared to 68 days).46,50 The vivatan
endoprothesis, with its smoother surface, is also consid-
ered to delay obstruction.44 Pig-tails and side openings
are also supposed to delay obstruction.4,44
Regular Endoprothesis Replacement
Most endoscopy experts recommend regular replace-
ment of the endoprothesis every 4 months prior to ob-
struction, especially in high-risk patients, which are those
with prior history of endoprothesis obstruction.44
Endoprothesis Cleansing
Several researchers tried endoprothesis cleansing as
an alternative to endoprothesis replacement. This is made
possible by the stent retriever invented by Soehendra,
and the snare-over wire technique. However, the ben-
efits are minimal and there is the risk of biliary sepsis.44
Oral Antibiotics and Bile Salts
Most current clinical trials in preventing endoprothesis
obstruction use a combination of bile salts, such as
ursodeoxycholic acid or rowachol, to improve bile flow
with antibiotics. Among these studies, only one study
using ursodeoxycholic acid and norfloxacin has demon-
strated significant benefits.44,47,51
COMBINATION OF PERCUTANEOUS AND ENDO-
SCOPIC TRANSHEPATIC BILIARY DRAINAGE
The main cause of failure in internal endoscopic drain-
age is obstruction at the duodenum and failure of the
canule to pass through the common bile duct or to pass
through the stricture. In such cases, a combination of
the percutaneous rendezvous and endoscopic technique
may be performed.4,32,52 In this procedure, the guide wire
is inserted percutaneously through the stricture area and
Table 6. Late onset complications of endoprothesis insertion.4,32 
Complications Incidence rate (%)   
Obstruction 21-36   
Acute cholecystitis 0-1   
Endoprothesis dislocation 0-1   
Perforation 1-2   
Duodenal stenosis 2-23 Ampulla 23 
  Pancreas 7.5 
  Gallbladder 5 
  Bifurcation 5 
Death Rare   
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Figure 6. Endoprothesis insertion using a combination of
percutaneus transhepatic biliary drainage and endoscopic
biliary drainage36
is then removed through an endoscope. The catheter
and endoprothesis is then inserted through the endo-
scope.4
endoprothesis guided by Magnetic Resonance
Cholangiopancreatography (MRCP). This technique can
be used if endoscopic insertion fails. This technique also
reduces the incidence of cholangitis up to 6%.53
Choice of Drainage Technique
The choice between surgical or non-surgical drain-
age is still controversial. In general, for patients with a
life expectancy of less than 6 month, non-surgical drain-
age seems to be more favorable. But for patients with a
longer life expectancy, palliative surgical treatment is more
advantageous.19
Which technique to chose usually depends on the
availability of expert and instrumentation at each institu-
tion.3,11,19 Beyer III, et al, proposed an algorithm based
on the site of obstruction, hemostasis function, and dila-
tation of the biliary duct, as seen in Illustration 8.11
The latest recommendation from American Society
for Gastrointestinal Endoscopy prefers the endoscopic
biliary drainage as the first choice, followed by a second
endoscopic trial, followed by other techniques such as
the PTBD, or a combination of both efforts, or surgical
drainage if all else fails.54,55
MRCP-GUIDED ENDOPROTHESIS INSERTION
Another alternative technique is by inserting the
Coagulopathy?
(thrombocyte<50.000/mL;
INR<1,4)
Biliary duct dilatation
(CT/USG)?
Location of
obstruction
Coagulopathy
improvement
PTCERCP
NO
Yes
No
No
ProximalDistal
Figure 7. Choice of non-operative technique to reach the biliary system.11
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Figure 8. The algorithm for the therapeutic approach towards biliarly obstruction due to malignancy.54
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CONCLUSION
1. Management of biliary obstruction due to malignancy
requires cooperation between the internist, surgeon,
and radiologist.
2. Non-surgical biliary drainage is the chosen palliative
treatment for biliary obstruction due to malignancy
with a life expectancy of less than six months, since
it has a lower rate of complication than surgical drain-
age.
3. The choice for non-surgical drainage technique de-
pends on the type of tumor, location of obstruction,
and the availability of experts and instrumentation.
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